Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

2.91
-0.0312-1.06%
Volume:69.38K
Turnover:201.88K
Market Cap:19.71M
PE:-0.42
High:2.94
Open:2.94
Low:2.88
Close:2.94
Loading ...

BriaCell reports iDSMB has completed third scheduled safety data review

TIPRANKS
·
24 Jun

BriaCell Reports Increased Losses in Latest Financials

TIPRANKS
·
18 Jun

BriaCell Therapeutics Q3 EPS $(1.64) Down From $1.61 YoY

Benzinga
·
17 Jun

Briacell Therapeutics Corp expected to post a loss of $1.76 a share - Earnings Preview

Reuters
·
14 Jun

Briacell Therapeutics Corp expected to post a loss of $1.76 a share - Earnings Preview

Reuters
·
11 Jun

BriaCell Therapeutics Schedules Virtual Investor Presentations for June 2025

TIPRANKS
·
04 Jun

BriaCell reports overall survival, clinical benefit data at ASCO 2025

TIPRANKS
·
02 Jun

BriaCell Bria-OTS Phase 1/2 study clears safety evaluation

TIPRANKS
·
27 May

BriaCell announces presentation of survival, clinical benefit data at ASCO 2025

TIPRANKS
·
23 May

BriaCell Therapeutics Advances in Cancer Immunotherapy with Promising Clinical Results

TIPRANKS
·
20 May

BriaCell CEO Letter to Shareholders

GlobeNewswire
·
20 May

BriaCell presents preclinical data from Phase 3 study of Bria-IMT

TIPRANKS
·
30 Apr

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

GlobeNewswire
·
30 Apr

BriaCell Therapeutics Closes $13.8 Million Public Offering

TIPRANKS
·
29 Apr

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

GlobeNewswire
·
29 Apr

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

GlobeNewswire
·
28 Apr

Wall Street Set to Open Lower Friday Amid Slew of Earnings Reports

MT Newswires Live
·
25 Apr

BriaCell Therapeutics to Raise $13.8 Million in Public Offering; Shares Fall

MT Newswires Live
·
25 Apr

BriaCell Therapeutics Announces $13.8 Million Public Offering

TIPRANKS
·
25 Apr

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

GlobeNewswire
·
25 Apr